CN1319566C - Ointment for treating rheumatic disease - Google Patents
Ointment for treating rheumatic disease Download PDFInfo
- Publication number
- CN1319566C CN1319566C CNB2003101114336A CN200310111433A CN1319566C CN 1319566 C CN1319566 C CN 1319566C CN B2003101114336 A CNB2003101114336 A CN B2003101114336A CN 200310111433 A CN200310111433 A CN 200310111433A CN 1319566 C CN1319566 C CN 1319566C
- Authority
- CN
- China
- Prior art keywords
- grams
- ointment
- gram
- raw
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to an ointment for treating rheumatism, which is characterized in that traditional Chinese medicine is ground into fine powder, and the fine powder is prepared into the ointment by a new substrate method, wherein the traditional Chinese medicine comprises 90 to 110 grams of Chinese clematis, 45 to 55 grams of raw arisaema, 45 to 55 grams of raw pinellia, 45 to 55 grams of raw wild aconite, 45 to 55 grams of raw Sichuan axonite root, 45 to 55 grams of white mustard seed, 45 to 55 grams of croton frost, 45 to 55 grams of pangolin scale, 45 to 55 grams of carbonized human hair, 45 to 55 grams of stir-frying donkey's hoof and 45 to 55 grams of stir-frying buffalo horn. The ointment has the advantages of appropriate selection of medicinal materials, reasonable compatibility and direct adhesion to afflicted parts, such as joints and other parts. Medicine can permeate to afflicted parts easily so as to treat rheumatism, and the ointment has the characteristic of rapidness for taking effect. If patients take orally-taken medicine cooperatively according to different constitutions, curative effects for consolidating the constitutions and getting double results with half effort can be achieved.
Description
Technical field:
The invention belongs to a kind of external-applied ointment for the treatment of arthromyodynias such as rheumatism, rheumatoid, gout.
Background technology:
Rheumatism or to be referred to as the arthromyodynia cause be human nutrition imbalance, the damp and hot heresy that is affected by the cold is closed and is disease.With the passing of time give birth in weakened body resistance that expectorant is turbid, blood stasis, pyretic toxicity, good and evil are fought mutually, it is foster that the QI and blood numbness resistance of meridians, skin, blood vessels, muscles and bones even internal organs is lost in moistening, and limbs, joint, myalgia, swelling occur, ache, numb, weighing distortion, the stiff and movable feature of being obstructed, general name rheumatism.To arthromyodynia, medicine orally taken for curing such as Chinese medicine adopts expelling wind and cold mostly, removes damp and clearing heat, collateral dredging reduces phlegm.And doctor trained in Western medicine is promptly based on anti-inflammatory analgetic.Two kinds of methods all can be to disease up to mitigation, but can't eliminate the expectorant stasis of blood, and healing often is difficult to be completely cured.Trace it to its cause the first: the living getting customs clearance of expectorant stasis of blood joint, joint, upper strata are invaded gradually, and joint is raised and met vital QI flowing in the body against the natural law inside, treat that the human body weakness holds void and go into, the effect of the air slaking fire cold and heat humidifying stasis of blood produces inflammation, and pressuring nerve muscle arteries and veins causes handicapped, numbness is ached, and muscle is difficult to stretch song, and is handicapped; It two is: the expectorant stasis of blood exists to take medicine on joint upper strata, joint and is difficult to break through its affinity, and difficult recovery from illness.Agglomerative rheumatism source can't can't be eliminated with capillary tube volatilization again from the intestines and stomach venting, so medicine is attacked to drawing the blood dissipating blood stasis and is difficult to reach effect; If employing traction physical therapy, massage, electrotherapy, baking the affected part after applying some drugs, medicine soup dip, mes therapy etc. also can demutations.
Summary of the invention:
The objective of the invention is according to traditional medical theory, interior disease outer treating method is invented the rheumatismal external-applied ointment of a kind of treatment, cooperates endo-medicine and reaches the radical cure arthromyodynia.
Technical solution of the present invention is achieved in that a kind of ointment for treating rheumatism, it is characterized in that the Chinese crude drug composition is respectively: Radix Clematidis 90-110 gram, Rhizoma Arisaematis 45-55 gram, Rhizoma Pinelliae 45-55 gram, Radix Aconiti Kusnezoffii 45-55 gram, Radix Aconiti 45-55 gram, Semen Sinapis Albae 45-55 gram, Semen Crotonis Pulveratum 45-55 gram, Squama Manis 45-55 gram, Crinis Carbonisatus 45-55 gram, charcoal of Ungula Equi Asini 45-55 gram, Cornu Bubali charcoal 45-55 gram by making ointment with conventional system cream method behind the Chinese crude drug porphyrize.Above-mentioned medical material ground into powder directly be attached to the affected part after making cream, can thoroughly transfer to rheumatism external, wherein Semen Crotonis Pulveratum, Rhizoma Arisaematis, Rhizoma Pinelliae, Radix Aconiti, Radix Aconiti Kusnezoffii can dissolve the rheumatism source, Squama Manis, charcoal of Ungula Equi Asini can be held out the rheumatism source of fusing, add that Semen Sinapis Albae, Radix Clematidis can transfer to externally, Crinis Carbonisatus can end capillary hemorrhage, more than the ointment made of each medicine compatibility can produce the effect in the wet source of wind turning.
The present invention has that medical material is selected suitably, compatibility rationally, directly is affixed on affected parts such as joint joint, and medicine is easy to infiltrate through focus, rheumatism is transferred to external, has the characteristics of instant effect.If the patient according to different body constitution is aided with oral medicine, can reaches to consolidate and radically reform, the therapeutical effect that gets twice the result with half the effort.
The specific embodiment:
Get Radix Clematidis 100 grams, Rhizoma Arisaematis 50 grams, Rhizoma Pinelliae 50 grams, Radix Aconiti Kusnezoffii 50 grams, Radix Aconiti 50 grams, Semen Sinapis Albae 50 grams, Semen Crotonis Pulveratum 50 grams, Squama Manis 50 grams, Crinis Carbonisatus 50 grams, charcoal of Ungula Equi Asini 50 grams, Cornu Bubali charcoal 50 grams by prescription.Make ointment with new substraturn approach below medical material porphyrize to 110 order.Described new substrate is existing conventional system cream method, is meant and utilizes own rare, the stupid first two-phase fourth fat of polychlorostyrene, Colophonium, zinc oxide as substrate.
Be according to the different body constitution of patient below, list the prescription example of some typical oral medicine, as:
1, anemofrigid-damp arthralgia, the prescription composition has: the Rhizoma alpiniae chinensis Radix Angelicae Pubescentis Ramulus Cinnamomi TUWAN Caulis Piperis Kadsurae Ramulus Mori Radix Angelicae Sinensis Rhizoma Chuanxiong Olibanum Radix Aucklandiae is anti-rich.
2, cold-damp numbness, the prescription composition has: Aconitum carmichjaelii Debx. Radix Aconiti Lateralis Preparata Cortex Cinnamomi Herba Asari Fructus Zanthoxyli Radix Angelicae Pubescentis TUWAN Radix Paeoniae Alba Radix Glycyrrhizae.
3, rheumatism numbness, the prescription composition has: the Rhizoma alpiniae chinensis Radix Angelicae Pubescentis Ramulus Cinnamomi TUWAN Caulis Piperis Kadsurae Ramulus Mori Radix Angelicae Sinensis Rhizoma Chuanxiong Olibanum Radix Aucklandiae is prevented rich Radix Stephaniae Tetrandrae Rhizoma Atractylodis Semen Coicis Radix Aconiti Lateralis Preparata Radix Clematidis Rhizoma Curcumae Longae.
4, damp and hot numbness, the prescription composition has: Rhizoma Anemarrhenae Gypsum Fibrosum Rhizoma Atractylodis Radix Glycyrrhizae Bombyx mori L. Semen Coicis Semen Phaseoli.
5, the uncomfortable disease of nutrition, the prescription composition has: Ramulus Cinnamomi Radix Aconiti Lateralis Preparata Radix Glycyrrhizae Rhizoma Zingiberis Recens Fructus Jujubae is prevented rich astragalus atractylodes.
Claims (2)
1, a kind of ointment for treating rheumatism, it is characterized in that the Chinese crude drug composition is respectively: Radix Clematidis 90-110 gram, Rhizoma Arisaematis 45-55 gram, Rhizoma Pinelliae 45-55 gram, Radix Aconiti Kusnezoffii 45-55 gram, Radix Aconiti 45-55 gram, Semen Sinapis Albae 45-55 gram, Semen Crotonis Pulveratum 45-55 gram, Squama Manis 45-55 gram, Crinis Carbonisatus 45-55 gram, charcoal of Ungula Equi Asini 45-55 gram, Cornu Bubali charcoal 45-55 gram by making ointment with conventional system cream method behind the Chinese crude drug porphyrize.
2, ointment for treating rheumatism according to claim 1, the fineness that it is characterized in that the Chinese crude drug porphyrize is below 110 orders.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101114336A CN1319566C (en) | 2003-11-19 | 2003-11-19 | Ointment for treating rheumatic disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101114336A CN1319566C (en) | 2003-11-19 | 2003-11-19 | Ointment for treating rheumatic disease |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1618442A CN1618442A (en) | 2005-05-25 |
CN1319566C true CN1319566C (en) | 2007-06-06 |
Family
ID=34759406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2003101114336A Expired - Fee Related CN1319566C (en) | 2003-11-19 | 2003-11-19 | Ointment for treating rheumatic disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1319566C (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100427062C (en) * | 2005-07-06 | 2008-10-22 | 甘肃奇正藏药有限公司 | Tibetan medicine for major functions of acute-chronic sprain-contusion, rheumatism, rheumatoid diseases, and its preparing method |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1076117A (en) * | 1993-01-06 | 1993-09-15 | 张良华 | The production method of tablets for eliminating blood stasis and promoting blood circulation |
CN1270053A (en) * | 1999-03-24 | 2000-10-18 | 马焕召 | Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof |
CN1439385A (en) * | 2002-02-23 | 2003-09-03 | 李洪杰 | Chinese medicine for rheumatism |
-
2003
- 2003-11-19 CN CNB2003101114336A patent/CN1319566C/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1076117A (en) * | 1993-01-06 | 1993-09-15 | 张良华 | The production method of tablets for eliminating blood stasis and promoting blood circulation |
CN1270053A (en) * | 1999-03-24 | 2000-10-18 | 马焕召 | Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof |
CN1439385A (en) * | 2002-02-23 | 2003-09-03 | 李洪杰 | Chinese medicine for rheumatism |
Also Published As
Publication number | Publication date |
---|---|
CN1618442A (en) | 2005-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1424024A (en) | External used paste for orthopedic diseases | |
CN101129595A (en) | Traditional Chinese medicine for treating lumbago due to kidney deficiency | |
CN102397506A (en) | Notoginseng paste for treating ostealgia | |
CN101554430B (en) | Medicinal liquor for treating rheumatic sciatica | |
CN100998656A (en) | Medicated wine for tonifying bone and removing obstruction in channels | |
CN102343076A (en) | Traumatic injury treatment ointment medicament for external application and production method thereof | |
CN102475868B (en) | Anti-rheumatism medicinal liquor | |
WO2017220052A2 (en) | Formulation treating rheumatoid bone pain | |
CN101130052A (en) | Traditional Chinese medicine for treating postpartum arthralgia | |
CN101002848B (en) | Medicine for treating recurrent uarthritis, and its preparing method | |
CN1319566C (en) | Ointment for treating rheumatic disease | |
CN105232905A (en) | Traditional Chinese medicine preparation for treating hyperostosis and preparing method of traditional Chinese medicine preparation | |
CN104547117A (en) | Traditional Chinese medicine preparation for treating gonarthromeningitis | |
CN101347558A (en) | Chinese medicine for treating rheumatism osteonosus | |
CN101444581A (en) | Externally used Pain-removal plaster for curing arthralgia | |
CN101099848A (en) | Traditional Chinese medicine powder agent for treating rheumatic arthritis, rheumatoid arthritis and ostealgia | |
CN105326926B (en) | A kind of external medicine preparation that treating muscles along the regular meridians disease, preparation method and application | |
CN103977308A (en) | Tradition Chinese medicine composition for treating ankylosing spondylitis | |
CN1242761C (en) | Numbness-activating blood-circulation-promoting pain-relieving ointment | |
CN103550446B (en) | Traditional Chinese medicine composition for external use to treat rheumatoid arthritis and application of traditional Chinese medicine composition | |
CN103463304B (en) | One treats arthroncus of knee Chinese medicine | |
CN105412692A (en) | Traditional Chinese medicine preparation for treating arthroncus of knees | |
CN101721669A (en) | Traditional Chinese medicine composition for treating cold dampness type sciatica | |
CN104721427A (en) | Traditional Chinese medicine preparation for treating rheumatic bone diseases | |
CN100998853A (en) | Chinese medicine for treating articular disease and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070606 Termination date: 20111119 |